Market Research Report
EU15 Spinal Implants & VCF Device Market Analysis-COVID19-2020-2026-MedSuite-Includes: Cervical Fixation, Thoracolumbar Fixation, Motion Preservation, Vertebral Compression Fracture, Spinal Surgery Instrumentation & Interbody Devices
|Published by||iData Research Inc.||Product code||1000910|
|Published||Content info||897 Pages
Delivery time: 1-2 business days
|EU15 Spinal Implants & VCF Device Market Analysis-COVID19-2020-2026-MedSuite-Includes: Cervical Fixation, Thoracolumbar Fixation, Motion Preservation, Vertebral Compression Fracture, Spinal Surgery Instrumentation & Interbody Devices|
|Published: March 19, 2021||Content info: 897 Pages||
Throughout this medical market research, the publisher analyzed 50+ Spinal Implant & Vertebral Compression Fracture Device companies in Europe and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this report suite report contains all of the EU15 Spinal Implant & VCF Device market analysis, each of the market segments is also available as a stand-alone a report, MedCore.
Overall, the European spinal implants and VCF market was valued at €1.46 billion in 2020 and is expected to grow over the forecast period to exceed €1.87 billion in 2026.
Despite many challenges, growth is expected in many market segments, as the patient demographics in Europe maintain a steady demand for such procedures. Growth has slowed in the last few years as newer, minimally invasive innovations gradually cannibalized the traditional spine market. In addition, the conservative approach of institutions regarding alternatives like motion preservation may limit growth in these segments, in contrast to other world markets.
The leading competitor in the European spinal implant market is Medtronic. The company holds the leading position in the VCF and motion preservation device markets and the second-leading position in the cervical fixation, thoracolumbar fixation and interbody device markets. Medtronic's strong position in the VCF market can be attributed to Kyphon's former monopoly of the percutaneous vertebral augmentation market, with its kyphoplasty product line.
Throughout this research series, the publisher has covered several countries in great detail. The countries covered are: